| Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines K Kisand, AS Bøe Wolff, KT Podkrajšek, L Tserel, M Link, KV Kisand, ... Journal of Experimental Medicine 207 (2), 299-308, 2010 | 730 | 2010 |
| Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cells O Bruserud, C Stapnes, E Ersvaer, BT Gjertsen, A Ryningen Current pharmaceutical biotechnology 8 (6), 388-400, 2007 | 186 | 2007 |
| The proteasome inhibitors bortezomib and PR‐171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells C Stapnes, AP Døskeland, K Hatfield, E Ersvær, A Ryningen, JB Lorens, ... British journal of haematology 136 (6), 814-828, 2007 | 144 | 2007 |
| Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation L Cassetta, K Bruderek, J Skrzeczynska-Moncznik, O Osiecka, X Hu, ... Journal for immunotherapy of cancer 8 (2), 2020 | 132 | 2020 |
| Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells E Ersvaer, K Liseth, J Skavland, BT Gjertsen, Ø Bruserud BMC immunology 11, 1-12, 2010 | 97 | 2010 |
| Heat shock protein 90-a potential target in the treatment of human acute myelogenous leukemia H Reikvam, E Ersvaer, O Bruserud Current cancer drug targets 9 (6), 761-776, 2009 | 74 | 2009 |
| Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators K Hatfield, AM Øyan, E Ersvaer, KH Kalland, P Lassalle, BT Gjertsen, ... British journal of haematology 144 (1), 53-68, 2009 | 73 | 2009 |
| The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity E Ersvaer, AO Kittang, P Hampson, K Sand, BT Gjertsen, JM Lord, ... Toxins 2 (1), 174-194, 2010 | 72 | 2010 |
| Interleukin-6 in allogeneic stem cell transplantation: its possible importance for immunoregulation and as a therapeutic target THA Tvedt, E Ersvaer, AA Tveita, Ø Bruserud Frontiers in immunology 8, 262167, 2017 | 65 | 2017 |
| Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte-and platelet … ÇA Akkök, K Liseth, T Hervig, A Ryningen, Ø Bruserud, E Ersvær Cytotherapy 11 (6), 749-760, 2009 | 61 | 2009 |
| Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2: Bax ratio and … A Ryningen, E Ersvær, AM Øyan, KH Kalland, OK Vintermyr, BT Gjertsen, ... Leukemia research 30 (12), 1531-1540, 2006 | 61 | 2006 |
| Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status … H Reikvam, KJ Hatfield, E Ersvaer, R Hovland, J Skavland, BT Gjertsen, ... British journal of haematology 156 (4), 468-480, 2012 | 57 | 2012 |
| The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia H Fredly, E Ersvær, AO Kittang, G Tsykunova, BT Gjertsen, Ø Bruserud Clinical epigenetics 5, 1-15, 2013 | 54 | 2013 |
| Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I ASB Wolff, BEV Oftedal, K Kisand, E Ersvaer, K Lima, ES Husebye Scandinavian journal of immunology 71 (6), 459-467, 2010 | 53 | 2010 |
| Long‐term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells K Liseth, E Ersvær, JF Abrahamsen, I Nesthus, A Ryningen, Ø Bruserud Transfusion 49 (8), 1709-1719, 2009 | 52 | 2009 |
| Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and … H Reikvam, KJ Hatfield, P Lassalle, A Olsnes Kittang, E Ersvaer, ... Expert opinion on investigational drugs 19 (2), 169-183, 2010 | 49 | 2010 |
| Myeloid-derived suppressor cells in hematologic diseases: promising biomarkers and treatment targets N Bizymi, S Bjelica, AO Kittang, S Mojsilovic, M Velegraki, C Pontikoglou, ... HemaSphere 3 (1), e168, 2019 | 48 | 2019 |
| Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis H Fredly, E Ersvær, BT Gjertsen, Ø Bruserud Oncology reports 25 (6), 1549-1556, 2011 | 46 | 2011 |
| Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia‐associated antigen associated with autoantibody … E Ersvaer, JY Zhang, E McCormack, A Olsnes, N Ånensen, E M. Tan, ... European Journal of Haematology 79 (3), 210-225, 2007 | 44 | 2007 |
| Effects of interferon gamma on native human acute myelogenous leukaemia cells E Ersvaer, J Skavland, E Ulvestad, BT Gjertsen, Ø Bruserud Cancer Immunology, Immunotherapy 56, 13-24, 2007 | 43 | 2007 |
Bjorn T. GjertsenProfessor of Hematology, University of BergenAdresse e-mail validée de uib.no
